Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Akorn's Delay Moving Three Generics To OTC Leads To $7.9M Settlement In Medicare Billing Complaint
Whistleblower Behind Federal Complaint Will Receive $946,000 From Settlement
Sep 27 2022
•
By
Rosalind Rei
• Source: Shutterstock
More from Rx-to-OTC Switch
More from Health